Heiko Lickert Selected Research

Type 4 Maturity-Onset Diabetes of the Young

1/2018	Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
1/2016	Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
1/2016	Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heiko Lickert Research Topics

Disease

7	Neoplasms (Cancer) 03/2022 - 09/2011
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2014
4	Obesity 01/2021 - 01/2017
3	Mason-Type Diabetes 01/2018 - 01/2016
3	Type 4 Maturity-Onset Diabetes of the Young 01/2018 - 01/2016
2	Inflammation (Inflammations) 03/2022 - 10/2017
2	Disease Progression 12/2021 - 07/2015
2	Body Weight (Weight, Body) 01/2021 - 01/2021
2	Diabetes Mellitus 12/2019 - 01/2017
2	Insulin Resistance 01/2019 - 10/2017
2	Tetraploidy 08/2013 - 09/2008
1	AIDS-Related Complex (ARC) 11/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022
1	Squamous Cell Carcinoma of Head and Neck 03/2022
1	Hypoxia (Hypoxemia) 03/2022
1	Infections 01/2021
1	Insulinoma 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	COVID-19 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Cysts 12/2019
1	Pancreatic Cyst 12/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Glucose Intolerance 01/2019
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2019
1	Osteoporosis 07/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2014
1	Melanoma (Melanoma, Malignant) 06/2012

Drug/Important Bio-Agent (IBA)

5	Insulin (Novolin)FDA Link 01/2022 - 07/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2017
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 09/2011
2	Hormones (Hormone)IBA 01/2021 - 10/2020
2	Blood Glucose (Blood Sugar)IBA 12/2019 - 01/2017
2	IncretinsIBA 10/2017 - 01/2017
2	Pharmaceutical PreparationsIBA 03/2016 - 07/2015
1	Aldehyde Dehydrogenase 1 FamilyIBA 11/2022
1	SugarsIBA 11/2022
1	Glial Fibrillary Acidic ProteinIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 03/2022
1	Coloring Agents (Dyes)IBA 01/2021
1	gastric inhibitory polypeptide receptorIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Codon (Codons)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	matrigelIBA 12/2019
1	TEMPOIBA 12/2019
1	Amino Acids FDA Link 01/2019
1	TankyrasesIBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 01/2019
1	GlucocorticoidsIBA 10/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2016
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2015
1	Cadherins (E-Cadherin)IBA 10/2015
1	CateninsIBA 08/2013
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2012
1	beta CateninIBA 09/2008

Therapy/Procedure

3	Therapeutics 03/2022 - 10/2017
1	Radiotherapy 03/2022
1	Glycemic Control 06/2014